Skip to main content

MIS416

Search complete. 7 mentions across 1 episode found for "MIS416".

Sep 29, 2026

Hamish HodderSOUNDBITE_SPEAKER
64:48
... shareholders of Innate Immunotherapeutics.
Hamish HodderSOUNDBITE_SPEAKER
64:52
It was an Australian biopharmaceuticals company with just one major product, MIS416.
Hamish HodderSOUNDBITE_SPEAKER
64:59
It's a drug that aims to provide symptom relief to patients with secondary progressive multiple sclerosis.
Hamish HodderSOUNDBITE_SPEAKER
65:06
The phase 2B clinical trial began in October of 2014, and the entire fate of the company rested on its success.

1 HR 3 MINS LATER

Hunter HancockSOUNDBITE_SPEAKER
128:40
No way.
Hunter HancockSOUNDBITE_SPEAKER
128:41
What? Check the box.
Hunter HancockSOUNDBITE_SPEAKER
128:43
And when we'd go to BJ's, I'd only grab products with th-
Joe BartolozziHOST
128:46
Oh, everybody's Mushari.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.